GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Varian Medical Systems Inc (NYSE:VAR) » Definitions » Intrinsic Value: Projected FCF

Varian Medical Systems (Varian Medical Systems) Intrinsic Value: Projected FCF : $60.39 (As of Apr. 26, 2024)


View and export this data going back to 1976. Start your Free Trial

What is Varian Medical Systems Intrinsic Value: Projected FCF?

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.

As of today (2024-04-26), Varian Medical Systems's Intrinsic Value: Projected FCF is $60.39. The stock price of Varian Medical Systems is $177.07. Therefore, Varian Medical Systems's Price-to-Intrinsic-Value-Projected-FCF of today is 2.9.

The historical rank and industry rank for Varian Medical Systems's Intrinsic Value: Projected FCF or its related term are showing as below:

VAR' s Price-to-Projected-FCF Range Over the Past 10 Years
Min: 2.06   Med: 2.37   Max: 2.93
Current: 2.93

During the past 13 years, the highest Price-to-Intrinsic-Value-Projected-FCF of Varian Medical Systems was 2.93. The lowest was 2.06. And the median was 2.37.

VAR's Price-to-Projected-FCF is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 1.69 vs VAR: 2.93

Varian Medical Systems Intrinsic Value: Projected FCF Historical Data

The historical data trend for Varian Medical Systems's Intrinsic Value: Projected FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Varian Medical Systems Intrinsic Value: Projected FCF Chart

Varian Medical Systems Annual Data
Trend Sep11 Sep12 Sep13 Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20
Intrinsic Value: Projected FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 53.04 50.97 51.71 53.07 58.87

Varian Medical Systems Quarterly Data
Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20
Intrinsic Value: Projected FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 52.96 49.94 54.85 58.87 60.57

Competitive Comparison of Varian Medical Systems's Intrinsic Value: Projected FCF

For the Medical Instruments & Supplies subindustry, Varian Medical Systems's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Varian Medical Systems's Price-to-Projected-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Varian Medical Systems's Price-to-Projected-FCF distribution charts can be found below:

* The bar in red indicates where Varian Medical Systems's Price-to-Projected-FCF falls into.



Varian Medical Systems Intrinsic Value: Projected FCF Calculation

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.

The details of how we calculate the intrinsic value of stocks are described in detail here.

This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + 0.8 * Total Stockholders Equity (most recent) ) / Shares Outstanding (Diluted Average)

In the case of negative Total Stockholders Equity, the following formula is used (see Explanation section below for the reason):

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + Total Stockholders Equity (most recent) / 0.8 ) / Shares Outstanding (Diluted Average)


Add all the Free Cash Flow together and divide 6 will get Varian Medical Systems's Free Cash Flow(6 year avg) = $358.32.

Varian Medical Systems's Intrinsic Value: Projected FCF for today is calculated as

Intrinsic Value: Projected FCF=(Growth Multiple*Free Cash Flow (6 year avg)+Total Stockholders Equity (Dec20)*0.8)/Shares Outstanding (Diluted Average)
=(10.551003399274*358.32+2238.3*0.8)/92.200
=60.43

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Varian Medical Systems  (NYSE:VAR) Intrinsic Value: Projected FCF Explanation

The growth multiple is capped between 8.35 and 17.74.

Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.

Varian Medical Systems's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as

Price-to-Intrinsic-Value-Projected-FCF=Share Price/Intrinsic Value: Projected FCF
=177.07/60.425981974274
=2.93

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Varian Medical Systems Intrinsic Value: Projected FCF Related Terms

Thank you for viewing the detailed overview of Varian Medical Systems's Intrinsic Value: Projected FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Varian Medical Systems (Varian Medical Systems) Business Description

Traded in Other Exchanges
N/A
Address
3100 Hansen Way, Palo Alto, CA, USA, 94304-1038
Varian Medical Systems designs, manufactures, and sells radiation technology for use in two business segments: oncology systems and proton therapy. The Americas account for the largest portion of revenue (47%), followed by Europe, the Middle East, and Africa (33%) and Asia-Pacific (19%).
Executives
Jesse Michael Bruff officer: SVP Finance, CFO 3100 HANSEN WAY, PALO ALTO CA 94304
Magnus Momsen officer: SVP, CAO, Corporate Controller VARIAN MEDICAL SYSTEMS INC. 3100 HANSEN WAY MAIL STOP E327 PALO ALTO CA 94304
Dow R Wilson director, officer: President and CEO VARIAN MEDICAL SYSTEMS INC, 3100 HANSEN WAY MAIL STOP E327, PALO ALTO CA 94304
Kolleen T Kennedy officer: Pres. Proton Solutions, CGO VARIAN MEDICAL SYSTEMS INC, 3100 HANSEN WAY MAIL STOP E327, PALO ALTO CA 94304
Christopher A. Toth officer: SVP and Pres. Oncology Systems 1252 COOLIDGE AVE., SAN JOSE CA 95125
Michael Damon Hutchinson officer: SVP,Chief Legal Officer, Secy 2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Jean Luc Butel director ONE BAXTER PARKWAY, DEERFIELD IL 60015
John W Kuo officer: SVP, Gen Counsel and Secretary VARIAN MEDICAL SYSTEMS INC, 3100 HANSEN WAY MAIL STOP E327, PALO ALTO CA 94304
Judy Bruner director C/O SANDISK CORPORATION, 601 MCCARTHY BLVD., MILPITAS CA 95035
Beau Michelle Le director 800 N. MICHIGAN AVENUE #3703 CHICAGO IL 60611
Anat Ashkenazi director LILLY CORPORATE CENTER, INDIANAPOLIS IN 46285
Jeffrey R. Balser director 3657 RICHLAND AVE., NASHVILLE TN 37205
Regina E Dugan director VARIAN MEDICAL SYSTEMS INC, 3100 HANSEN WAY MAIL STOP E327, PALO ALTO CA 94304
David J Illingworth director 3100 HANSEN WAY PALO ALTO CA 94304
R Andrew Eckert director THREE RAVINIA DRIVE, ATLANTA GA 30346

Varian Medical Systems (Varian Medical Systems) Headlines

From GuruFocus

Varian Announces CEO Succession Plan

By PRNewswire PRNewswire 03-02-2021